Reproducibility of the Motor Optimality Score-Revised in infants with an increased risk of adverse neurodevelopmental

Carly Luke1,2, Arend F Bos3, Michelle Jackman4,5

  • 1Queensland Cerebral Palsy and Rehabilitation Research Centre, Child Health Research Centre, The University of Queensland, Brisbane, Australia.

Insights

The Motor Optimality Score-Revised (MOS-R) shows good reproducibility for assessing infants at high risk of neurodevelopmental disorders. Consensus agreement among experienced assessors enhances its reliability in clinical settings.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Clinical Assessment Tools

Background:

  • Infants at high risk for adverse neurodevelopmental outcomes (ad-NDO) require reliable assessment tools.
  • The Motor Optimality Score-Revised (MOS-R) is utilized to evaluate neurodevelopmental trajectories.
  • Assessing the reproducibility of the MOS-R is crucial for its clinical application.

Purpose of the Study:

  • To determine the reproducibility of the Motor Optimality Score-Revised (MOS-R).
  • To assess the MOS-R's utility in identifying infants at high risk for cerebral palsy (CP), autism, and developmental delays.
  • To evaluate the feasibility of MOS-R implementation in clinical settings.

Main Methods:

  • Thirty infants (gestational age 23-41 weeks) with known 2-year outcomes were assessed.
  • Six independent assessors, masked to infant history, scored MOS-R from two General Movements videos per infant.
  • Interrater reliability was calculated using Intraclass Correlation Coefficient (ICC) and Gwet's agreement coefficient.

Main Results:

  • Combined interassessor reliability for total MOS-R was 'fair' (ICC=0.56), improving to 'excellent' with consensus agreement (ICC=0.99).
  • Reliability varied across subcategories, with 'movement patterns' showing highest agreement (Gwet's=0.73-1.00) and 'postural patterns' the lowest (0.45-0.73).
  • Higher reproducibility was observed when assessors scored two videos per infant and for typically developing infants compared to those with CP or ad-NDO.

Conclusions:

  • The MOS-R is a highly reproducible tool for assessing infants at high risk for ad-NDOs.
  • The MOS-R is feasible for clinical implementation, particularly when used by experienced assessors aiming for consensus.
  • Consensus agreement significantly enhances the reliability of MOS-R assessments.
Abstract

Related Concept Videos